ELUTIA INC. - CLASS A
3,6900
06-ноября-24 14:59:50
15 мин. задержка
Акции
-0,1400
-3,66%
Сегодняшний диапазон
3,5150 - 3,8800
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Aziyo Biologics to Present at the Cowen 43rd Annual Health Care Conference
27 фев 2023 07:15:00 Источник Nasdaq GlobeNewswire
-
09 янв 2023 07:15:00 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics Announces Funding of Additional $4 Million Term Loan with SWK Holdings Corporation
15 дек 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics, Inc. Announces Pricing of $11.2 Million Public Offering of Common Stock
01 дек 2022 08:04:00 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics, Inc. Announces Proposed Public Offering of Common Stock
30 ноя 2022 15:08:00 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics to Participate in Upcoming Investor Conferences
21 ноя 2022 15:05:00 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics Reports Strong Third Quarter 2022 Revenue
14 ноя 2022 15:01:00 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics to Report Third Quarter 2022 Financial Results on November 14, 2022
07 ноя 2022 15:05:01 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics Appoints Seasoned Healthcare Executive, David Colpman, to Board of Directors
24 окт 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics Strengthens Leadership Team and Organizes for Growth in Key Markets
11 окт 2022 15:35:48 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics Appoints Michelle LeRoux Williams, Ph.D as Chief Scientific Officer
26 авг 2022 08:00:00 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
17 авг 2022 15:05:00 Источник Nasdaq GlobeNewswire
-
11 авг 2022 15:05:02 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics Announces $25 Million Loan Facility with SWK Holdings
10 авг 2022 17:56:35 Источник Nasdaq GlobeNewswire
-
09 авг 2022 16:57:55 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics to Report Second Quarter 2022 Financial Results on August 11, 2022
28 июл 2022 15:05:00 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics Appoints Dr. C. Randal Mills as Interim President and CEO
21 июн 2022 15:05:00 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics Provides Business Update and Reports First Quarter 2022 Financial Results
09 май 2022 15:05:02 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics to Report First Quarter 2022 Financial Results on Monday, May 9, 2022
25 апр 2022 15:05:00 Источник Nasdaq GlobeNewswire
-
Aziyo Biologics Announces Upcoming KOL Call Hosted by Cowen
12 апр 2022 15:05:00 Источник Nasdaq GlobeNewswire